Showing 301 - 320 results of 324 for search '"indole"', query time: 0.06s Refine Results
  1. 301

    Brucellosis Presenting with Febrile Pancytopenia: An Atypical Presentation of a Common Disease and Review of Brucellosis by Carina Chang, Bryce D. Beutler, Mark B. Ulanja, Chukwudum Uche, Milan Zdrnja

    Published 2021-01-01
    “…Nevertheless, early detection and treatment are essential to reduce the risk of long-term sequelae that may result from chronic, indolent disease.…”
    Get full text
    Article
  2. 302

    Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic Review by Francesco Panzuto, Ludovica Magi, Gianluca Esposito, Maria Rinzivillo, Bruno Annibale

    Published 2021-01-01
    “…Endoscopic resection is considered the treatment of choice for type I gastric neuroendocrine neoplasia (gNEN) given its indolent behaviour; however, the favoured endoscopic technique to remove these tumours is not well established. …”
    Get full text
    Article
  3. 303

    Aggressive Differentiated Thyroid Cancer due to EML4e13-ALKe20 Fusion: A Case Presentation and Review of the Literature by Rodhan Khthir, Zainab Shaheen, Prasanna Santhanam, Saroj Sigdel

    Published 2021-01-01
    “…Differentiated thyroid cancer (DTC) is an indolent malignancy. It rarely presents with aggressive local invasion and/or distant metastatic disease. …”
    Get full text
    Article
  4. 304

    Lymphomatoid Papulosis Type E With T-Cell Receptor Gamma Positivity by Namasondhi A, Rutnin S, Jerasutus S, Boonsakan P, Triyangkulsri K

    Published 2025-01-01
    “…Clinically, it usually presents with a few large necrotic nodules or ulcers on the trunk or extremities, unlike other subtypes of LyP. Despite an indolent clinical course, long-term follow-up is necessary due to the risk of developing concurrent or secondary lymphoma. …”
    Get full text
    Article
  5. 305

    Rare Pathology Case Report: Low-Grade Endometrial Stromal Sarcoma Forming Sex Cord– and Endometrioid Gland–Like Differentiation in Metastatic Foci by Haneen Al-Maghrabi, Ghadeer Mokhtar, Jaudah Al-Maghrabi

    Published 2024-01-01
    “…Low-grade endometrial stromal sarcomas (LGESSs) are indolent tumors with a slow progression rate that tend to recur locally. …”
    Get full text
    Article
  6. 306

    Duodenal Gangliocytic Paraganglioma Requiring a Pancreaticoduodenectomy: A Case Report and Review of the Literature by Laurie Adams, Theodore M. Friedman, Timothy R. Shaver, George Younan

    Published 2018-01-01
    “…They have been associated with an indolent behavior; however, they can rarely metastasize. …”
    Get full text
    Article
  7. 307
  8. 308
  9. 309

    Response to Initial Therapy of Differentiated Thyroid Cancer Predicts the Long-Term Outcome Better than Classical Risk Stratification Systems by Albert Cano-Palomares, Ignasi Castells, Ismael Capel, Maria Rosa Bella, Santi Barcons, Angel Serrano, Xavier Guirao, Mercedes Rigla

    Published 2014-01-01
    “…Although differentiated thyroid cancer (DTC) usually has an indolent course, some cases show a poor prognosis; therefore, risk stratification is required. …”
    Get full text
    Article
  10. 310

    Myeloid Disease with the CSF3R T618I Mutation after CLL by Maria Eduarda Couto, Susana Bizarro, Domingos Sousa, Nelson Domingues, Isabel Oliveira, Gabriela Martins, Manuel R. Teixeira, Mário Mariz

    Published 2020-01-01
    “…Chronic lymphocytic leukemia (CLL) is frequently an indolent diagnosis, with most of the patients being under surveillance for long time. …”
    Get full text
    Article
  11. 311

    Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis by Scott F. Huntington, Sreevalsa Appukkuttan, Wenyi Wang, Yuxian Du, Sari Hopson, Svetlana Babajanyan

    Published 2022-10-01
    “…**Background:** A consensus is lacking on optimal treatment sequencing for follicular lymphoma (FL), the most common indolent lymphoma. FL is incurable, and many patients require multiple lines of therapy for successive relapses. …”
    Get full text
    Article
  12. 312

    Digital Gangrene: An Unusual Manifestation of Non-Hodgkin Lymphoma by Muhammad Shoaib Momen Majumder, Shamim Ahmed, Tajkia Haque, Syed Atiqul Haq, Saumitra Chakravarty, Md. Abu Shahin, Din-E-Mujahid Mohammad Faruque Osmany, Johannes J. Rasker

    Published 2022-01-01
    “…The clinical picture varies from indolent to aggressive presentation and nodal (lymphadenopathy) to extranodal (central nervous system, gastrointestinal, cutaneous plaque, or ulcer) involvement. …”
    Get full text
    Article
  13. 313

    Metastatic papillary thyroid carcinoma with internal jugular vein tumor thrombus - A case report and review of the literature by Zaina Adnan, Edmond Sabo, Sameer Kassem

    Published 2025-01-01
    “…Papillary thyroid carcinoma (PTC) is the most common malignancy of the thyroid gland, typically associated with an indolent course and favourable prognosis. However, although rare, PTC can demonstrate aggressive behaviour, including vascular invasion with extension into major vessels. …”
    Get full text
    Article
  14. 314

    Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study by I. Yu. Pirogova, S. V. Yakovleva, T. V. Neuymina, S. P. Sinitsyn, V. S. Chulkov, T. N. Shamaeva

    Published 2018-09-01
    “…The number of patients with indolent steatosis (less than 2nd stage) increased 2 times (p < 0.001). …”
    Get full text
    Article
  15. 315

    The natural course of cystic pancreatic neuroendocrine tumours in MEN1 by Eline N M van Vliembergen, Carolina R C Pieterman, Annenienke C van de Ven, Arthur J A T Braat, Gerlof D Valk, Joanne M de Laat

    Published 2025-02-01
    “…While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. …”
    Get full text
    Article
  16. 316

    Liquid-based cytological diagnosis of pancreatic neuroendocrine tumors using hyperspectral imaging and deep learning by Taojing Ran, Wei Huang, Xianzheng Qin, Xingran Xie, Yingjiao Deng, Yundi Pan, Yao Zhang, Ling Zhang, Lili Gao, Minmin Zhang, Dong Wang, Yan Wang, Qingli Li, Chunhua Zhou, Duowu Zou

    Published 2025-03-01
    “…The incidence of pancreatic neuroendocrine tumors (PanNETs), although uncommon, has recently increased, and they are almost always diagnosed in the late stages due to their indolent clinical manifestations. This study developed a method that combines hyperspectral imaging (HSI) technology and a convolutional neural network (CNN) to conduct a cytological diagnosis of PanNETs. …”
    Get full text
    Article
  17. 317

    Polymorphous Adenocarcinoma: A Rare Case Report with Unique Radiographic Appearance on CBCT by Jagadish Chandra, Junaid Ahmed, K. M. Veena, M. Vijayakumar, Nandita Shenoy, Nanditha Sujir

    Published 2021-01-01
    “…Polymorphous low-grade adenocarcinoma (PLGA) is a slow growing malignant tumor of minor salivary glands and is generally of indolent nature. However, according to the most recent WHO Classification of Salivary Gland Tumors (2017), the cancer is classified as Polymorphous AdenoCarcinoma (PAC). …”
    Get full text
    Article
  18. 318

    NON-FUNCTIONING SPORADIC PANCREATIC NEUROENDOCRINE TUMOR IS AN INDEPENDENT RISK FACTOR FOR RECURRENCE AFTER SURGICAL TREATMENT by Estela Regina Ramos Figueira, André Luis Montagnini, Jessica Okubo, Ana Gabriela Vivarelli Fernandes, Marina Alessandra Pereira, Ulysses Ribeiro Junior, Paulo Herman, José Jukemura

    Published 2025-01-01
    “…ABSTRACT BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) are uncommon and heterogeneous neoplasms, often exhibiting indolent biological behavior. Their incidence is rising, largely due to the widespread use of high-resolution imaging techniques, particularly influencing the diagnosis of sporadic non-functioning tumors, which account for up to 80% of cases. …”
    Get full text
    Article
  19. 319

    Case Report: The Versatile Art of Reconstruction: A Decade‐Long Journey With Recurrent Facial Basal Cell Carcinoma by T. H. Pathirana, V. Bandaranayake, A. P. Nellihela, S. Nikeshala, T. Saranga, A. Abegunasekara, S. Gunathilake, N. J. Asanthi

    Published 2025-01-01
    “…While most BCC is relatively indolent, aggressive subtypes, including infiltrative BCC, pose the treatment challenges of ensuring functional and aesthetic preservation with a high risk of recurrence. …”
    Get full text
    Article
  20. 320

    The Role of Small Bowel Capsule Endoscopy in Determining the Treatment Strategy for Duodenal Follicular Lymphoma: A Single-Center Retrospective Study by Donghoon Kang, Gi-June Min, Tong Yoon Kim, Young-Woo Jeon, Yukyung Cho, Jae Myung Park, Joo Hyun O, Byung-Ock Choi, Gyeongsin Park, Seok-Goo Cho

    Published 2025-01-01
    “…During follow-up (median, 48.4 months), two relapse events occurred in the advanced stage, with no lymphoma-associated deaths. DFL tends to be indolent and has favorable outcomes. <b>Conclusions</b>: Proactive VCE for diagnosing DFL is recommended to determine small bowel involvement, which may influence subsequent treatment decisions.…”
    Get full text
    Article